StuartAAaronsonMD
Family Medicine • New York, NYProfessor & Chair, Medicine, Icahn School of Medicine at Mount Sinai
Dr. Aaronson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Gustave L Levy Pl
New York, NY 10029- Is this information wrong?
Education & Training
University of California San Francisco School of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 1967 - Present
NY State Medical License 1971 - 2026
VA State Medical License 1971 - 2020
DC State Medical License 1974 - 1982
Publications & Presentations
PubMed
- 23 citationsROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.Davide Esposito, Ila Pant, Yao Shen, Rui F Qiao, Xiaobao Yang, Yiyang Bai, Jian Jin, Poulikos I Poulikakos, Stuart A Aaronson> ;Nature Communications. 2022 Feb 4
- 24 citationsHigh endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.Anita Rogic, Ila Pant, Luca Grumolato, Ruben Fernandez-Rodriguez, Andrew K. Edwards, Suvendu Das, Aaron Sun, Shen Yao, Rui Qiao, Shabnam Jaffer, Ravi Sachidanandam, Gu...> ;Nature Communications. 2021 Nov 25
- 28 citationsDistinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, Ruitong Li, Takahiro Ito, Tamer A. Ahmed, Zoi Karoulia, Christos Adamopoulos, Hong Wang, Li Wang, Ling Xie, Jing Liu, Beatrix Ueber...> ;Nature Cancer. 2021 Mar 1
- Join now to see all
Grant Support
- Training Program In Cancer BiologyNational Cancer Institute2010–2011
- P53 - Regulators And EffectorsNational Cancer Institute2010–2011
- Effectors Of P53 Pro-Survival And Pro-Apoptotic Signaling PathwaysNational Cancer Institute2010–2011
- Administrative CoreNational Cancer Institute2010–2011
- WNT Receptor Signaling And CancerNational Cancer Institute2005–2009
- Effectors Of P53 Pro-Survival &Pro-Apoptotic SignalingNational Cancer Institute2005–2009
- Training Program In Cancer BiologyNational Cancer Institute2001–2009
- P53 - Regulators And EffectorsNational Cancer Institute2000–2009
- Cellular Senescence In Aging And CancerNational Cancer Institute1999–2008
- Postdoctoral Training Program In Cancer BiologyNational Cancer Institute2005–2006
- Cancer Resource--Pathology, Registry And BiorepositoriesNational Cancer Institute2002–2006
- Administrative CoreNational Cancer Institute2005
- Cloning And Analysis Of WNT Receptors In Breast CancerNational Cancer Institute1997–2004
- MAPK In P53 Induced Growth Arrest/SenescenceNational Cancer Institute2000–2002
- Training Program In Cancer TherapyNational Cancer Institute1999–2000
- Targeting Hereditary Breast Cancers Through Elucidation Of BRCA1/2 Gene FunctionsNational Cancer Institute1998–1999
- Ras-Related Oncogenes In Human TumorsNational Cancer Institute1997–1999
- ERBB And Ras-Like Oncogene Interaction In Human Breast CancerNational Cancer Institute1996–1997
- Ras-Related Oncogenes In Human TumorsNational Cancer Institute1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
